Journal List > J Korean Ophthalmol Soc > v.50(1) > 1008389

Kwon, Oh, Lee, and Park: Three Cases of Corneal Tattooing for the Treatment of Traumatic Iris Defect

Abstract

Purpose

To investigate the effects of corneal tattooing on patients with a traumatic iris defect.

Case Summary

Corneal tattooing operation was performed on three patients (3 cases) with a traumatic iris defect. In case 1, the cornea was dyed with Davidson® marking dyes (Bradley Products Inc., MN, US) and the amniotic membrane with the central incision was permanently transplanted. In case 2, both corneal dyeing and permanent amniotic membrane transplantation were performed on the area of partial iris loss. In case 3, corneal dyeing was performed after the intrastromal cornea was dissected. Corneal reepithelization was found in the first 2 cases 12 and 9 days after amniotic membrane transplantation, respectively. Three months after the transplantation, all three cases showed an improvement in best corrected visual acuity (BCVA), with an increase of one or more lines on the Snellen Chart. Simultaneously, preoperative monocular contrast and glare were also found to beimproved in all three cases. In both cases 1 and 2, 60% of the initially used dyes still remained in the cornea 6 months after the surgery, and in case 3, 90% of the initial dye remained. Except for the moderate astigmatism found earlier after the surgery in case 3, no serious complications developed.

Conclusions

Corneal tattooing can improve the visual acuity and reduce glare in eyes with a traumatic iris defect and is cosmetically pleasing. Furthermore, corneal tattooing can be performed more easily and repeatedly than black diaphragm intraocular lens implantation.

References

1. Romem M, Singer L. Traumatic aniridia. Br J Ophthalmol. 1973; 57:613–4.
crossref
2. Trobe JD, Keeney AH. Traumatic aniridia. Am J Ophthalmol. 1974; 78:1006–8.
crossref
3. Milea D, Burillon C. Aniridia in a patient with tuberous sclerosis. Br J Ophthalmol. 1997; 81:804.
crossref
4. Shaffer RN, Cohen JS. Visual reduction in aniridia. J Pediatr Ophthalmol. 1975; 12:220–2.
crossref
5. Choyce P. Intraocular lenses and implants. London: HK Lewis;1964. p. 124–9.
6. Sundmacher R, Reinhard T, Althaus C. Black diaphragm intraocular lens for correction of aniridia. Ger J ophthalmol. 1994; 25:180–5.
7. Suh DS, Roh JH, Kim SD. Clinical experience with black- diaphragm intraocular lens in traumatic (Postoperative) aniridia and aphakia. J Korean Ophthalmol Soc. 1998; 39:1183–91.
8. Reinhard T, Sundmacher R. Black diaphragm aniridia intra-ocular lens for congenital aniridia: Long-term follow-up. J Cataract Refract Surg. 2000; 26:375–81.
crossref
9. Lee JJ, Lee SJ, Kim SD. Black diaphragm intraocular lens for traumatic aniridia: Long-term follow-up. J Korean Ophthalmol Soc. 2008; 49:238–44.
crossref
10. Remky A, Redbrake C, Wenzel M. Intrastromal corneal tattooing for iris defects. J Cataract Refract Surg. 1998; 24:1285–7.
crossref
11. Beekhuis WH, Drost BH, van der Velden/Samderubun EM. A new treatment for photophobia in posttraumatic aniridia: A case report. Cornea. 1998; 17:338–41.
12. Wachler BS, Krueger RR. Normalized contrast sensitivity values. J Refract Surg. 1998; 14:463–6.
crossref
13. Reed JW, Beran RF. Elimination of monocular diplopia by corneal tattooing. Ophthalmic Surg. 1988; 19:437–9.
crossref
14. Reed JW. Corneal tattooing to reduce glare in cases of traumatic iris loss. Cornea. 1994; 13:401–5.
crossref
15. Leigh AG. Tattooing of the cornea. Duke-Elder S, editor. System of ophthalmology. 1st. London: Henry Kimpton;1965. v. 8. chap. 5.
16. Sekundo W, Seifert P, Seitz B, Loeffler KU. Long term ultrastructural changes in human corneas after tattooing with non-metallic substances. Br J Ophthalmol. 1999; 83:219–24.
crossref
17. Olander K, Kanai A, Kaufman HE. An analytical electron microscopic study of a corneal tattoo. Ann Ophthalmol. 1983; 15:1046–9.
18. Wessels IF, Wessels GF. Mechanized keratomicropigmentation: Corneal tattooing with the blepharopigmentor. Ophthalmic Surg Lasers. 1996; 27:25–8.
crossref
19. Lee JE, Lee SU, Kim JH. . Corneal tattooing tomask the opacification after amniotic membrane grafting for corneal ulcer. J Korean Ophthalmol Soc. 2006; 47:1491–5.
20. Roper-Hall MJ. The conjunctiva, cornea, and sclera. In: Stallard HB. Stallard’s eye surgery. 7th. Kent: Butterworths;1989. v. 2. chap. 13.
21. Khan AO, Meyer D. Corneal tattooing for the treatment of debilitating glare in a child with traumatic iris loss. Am J Ophthalmol. 2005; 139:920–1.
crossref
22. Burris TE, Holmes-Higgin DK, Silvestrini TA. Lamellar intrastromal corneal tattoo for treating iris defects (Artificial iris). Cornea. 1998; 17:169–73.
crossref
23. Budavari S. The Merck index-an encyclopedia of chemicals, drugs, and biological. O’Neil MJ. The Merck index. 13th. New Jersey: Merck and Co. Inc.;1996. v. 8. chap. 1.
24. Hathaway GJ, Proctor NH, Hughes JP. Chemical hazards of the workplace. 3rd. Vol. 1. New York: Van Nostrand Reinhold;1991. p. 329–31.
25. Tang CK, Ahn HB, Park WC. The clinical effects of dye-amniotic membrane transplantation on bullous kerato-pathy. J Korean Ophthalmol Soc. 2003; 44:1741–7.
26. Kim YK, Han YK, Wee WR. . 7 Cases of combined corneal tattooing and amniotic membrane transplantation in bullous keratopathy. J Korean Ophthalmol Soc. 2008; 49:503–8.
crossref
27. Mejia LF, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002; 21:342–5.
crossref
28. Espana EM, Grueterich M, Sandoval H. . Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003; 29:279–84.
crossref
29. Pires RT, Tseng SC, Kim JC. . Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999; 117:1291–7.
crossref
30. Hersh PS, Shingleton BJ, Kenyon KR. Anterior segment trauma. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2nd. Philadelphia: PA Saunders;1994. v. 2. chap. 8.
31. Sundmacher R, Reihnhard T, Althaus C. Black diaphragm intraocular lens in congenital anridia. Ger J Ophthalmol. 1994; 3:197–201.
32. Thompson CG, Fawzy K, Bryce IG. . Implantation of a black diaphragm intraocular lens for traumatic aniridia. J Cataract Refract Surg. 1999; 25:808–13.
crossref

Figure 1.
Photograph shows an eye having traumatic aniridia (A). We performed both corneal tattooing and amniotic membrane transplantation with the central incision (B). Corneal reepithelialization was completely achieved on the postoperative second week (C). This shows the well-stained cornea on the postoperative third month, especially in terms of retroillumination (D). (Case 1)
jkos-50-151f1.tif
Figure 2.
Photograph shows a partial iris defect on the 6~10 o’clock direction (A). We first performed the transplantation of the already tattooed amniotic membrane (B). Four years later, the tattooed dyes were almost discolored (C). So we performed the second corneal tattooing and then both permanent and temporary amniotic membrane transplantation (D). No epithelial defect was found on the second week after the above second operation (E). This shows that the dyes of corneal tattooing and iris color are well matched with each other (F).(Case 2)
jkos-50-151f2.tif
Figure 3.
Photograph shows an eye having traumatic aniridia (A). We performed intrastromal corneal tattooing (B). The state of the tattooed cornea was well-maintained throughout the follow-up observation (C). This Pentacam Scheimfplug (Oculus inc., Germany) image shows the significant astigmatic eye on the postoperative first week (D). (Case 3)
jkos-50-151f3.tif
Figure 4.
These graphs show the test results of contrast sensitivity and glare. All three cases showed an improvement at all four spatial frequencies of cycles per degree (cpd) on the postoperative 3rd month. (Contrast sensitivity was measured with the Standard Version of the CSV-1000E Chart (VectorVision, US) in accordance with applicable standards developed by Boxer and Krueger.12
jkos-50-151f4.tif
TOOLS
Similar articles